Benlyazid Adil, Thariat Juliette, Temam Stephane, Malard Olivier, Florescu Carmen, Choussy Olivier, Makeieff Marc, Poissonnet Gilles, Penel Nicolas, Righini Christian, Toussaint Bruno, Lacau St Guily Jean, Vergez Sebastien, Filleron Thomas
Department of Head and Neck Surgery, Claudius Regaud Institute, 20-24 rue du pont Saint Pierre, Toulouse 31052, France.
Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1219-25. doi: 10.1001/archoto.2010.217.
to report patterns of failure according to treatment modality, with an emphasis on the role of postoperative radiotherapy in patients with localized head and neck mucosal melanoma (HNMM) treated during a 28-year period in a multi-institutional setting.
retrospective review.
french medical institutions.
a total of 160 patients with nonmetastatic HNMM treated from 1980 through 2008.
treatment modality consisted of surgery alone (hereinafter, S group) (n = 82 patients) or with postoperative radiotherapy (hereinafter, SRT group) (n = 78). Patients and tumor characteristics were similar in the 2 groups. There was a nonsignificant trend (P = .11) for more locally advanced tumor stage (38.9%) in the SRT group compared with the S group (24.5%).
patients in the S group had an increased probability of locoregional recurrence as a first event (55.6%) compared with those in the SRT group (29.9%; P < .01). After adjusting for tumor stage (T1/T2 vs T3/T4), the subdistribution hazard ratio of locoregional relapse was 0.31, (95% confidence interval [CI], 0.15-0.61; P < .01).The rate of distant metastasis as a first event was significantly higher in the SRT group (40.6%) compared with the S group (19.9%; P = .01). Regardless of their treatment, patients who had a locoregional relapse during follow-up had an increased risk of subsequent distant metastasis (hazard ratio, 3.07; 95% CI, 1.65-5.67) and death (hazard ratio, 3.01; 95% CI, 1.91-4.78).
this large retrospective study suggests that postoperative radiotherapy improves the locoregional control of HNMM. The higher rate of distant metastasis was due to more advanced disease in the SRT group.
根据治疗方式报告失败模式,重点关注术后放疗在多机构环境下28年期间治疗的局限性头颈部黏膜黑色素瘤(HNMM)患者中的作用。
回顾性研究。
法国医疗机构。
1980年至2008年期间共治疗160例非转移性HNMM患者。
治疗方式包括单纯手术(以下简称S组)(n = 82例患者)或术后放疗(以下简称SRT组)(n = 78例)。两组患者和肿瘤特征相似。SRT组局部晚期肿瘤分期(38.9%)较S组(24.5%)有不显著的增加趋势(P = 0.11)。
与SRT组(29.9%;P < 0.01)相比,S组患者作为首发事件的局部区域复发概率增加(55.6%)。在调整肿瘤分期(T1/T2与T3/T4)后,局部区域复发的亚分布风险比为0.31(95%置信区间[CI],0.15 - 0.61;P < 0.01)。SRT组作为首发事件的远处转移率(40.6%)显著高于S组(19.9%;P = 0.01)。无论接受何种治疗,随访期间发生局部区域复发的患者随后发生远处转移的风险增加(风险比,3.07;95% CI,1.65 - 5.67)和死亡风险增加(风险比,3.01;95% CI,1.91 - 4.78)。
这项大型回顾性研究表明,术后放疗可改善HNMM的局部区域控制。远处转移率较高是由于SRT组疾病更为晚期。